Läs mer
Invitrogen™ Human p21 (aa 45-155) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (77%), Rat (77%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Specifications
Specifications
| Tillträdesnummer | P38936 |
| Koncentration | ≥5.0 mg/mL |
| För användning med (applikation) | Blocking Assay, Control |
| Formulering | 1 M urea, PBS with no preservative; pH 7.4 |
| Gen-ID (Entrez) | 1026 |
| Namn | Human p21 (aa 45-155) Control Fragment |
| Kvantitet | 100 μL |
| Regulatorisk status | RUO |
| Gene Alias | Activating Fragment 1; CAP20; cdk inhibitor CIP1; cdk inhibitor CIP1 (p21); CDKI; CDK-interacting protein 1; CDK-interaction protein 1; Cdkn1; CDKN1A; CDNK1A; CIP1; Cip1); cyclin dependent kinase inhibitor 1 A; cyclin-dependent kinase inhibitor 1; cyclin-dependent kinase inhibitor 1 A; Cyclin-dependent kinase inhibitor 1 A (p21; cyclin-dependent kinase inhibitor 1 A (P21); cyclin-dependent kinase inhibitor 1 A (p21, Cip1); cyclin-dependent kinase inhibitor 1 A variant 1; cyclin-dependent kinase inhibitor 1 A variant 2; DNA synthesis inhibitor; MDA6; MDA-6; melanoma differentiation associated protein 6; melanoma differentiation-associated protein; Melanoma differentiation-associated protein 6; OTTHUMP00000016298; p21; p21Cip1; p21Cip1/Waf1; p21WAF; PIC1; putative cyclin-dependent kinase inhibitor 1 A (p21/WAF1/CIP1); SDI1; SLC12A9; UV96; WAF1; Wild type p53 activated fragment 1 (WAF1); wild-type p53-activated fragment 1 |
| Vanligt namn | p21 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.